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ABSTRACT 
In recent years, methicillin-resistant Staphylococcucs aureus  (MRSA) have become a truly global challenge.  Systemic review and 
meta-analysis was performed to summarize the prevalence of MRSA in different regions of Kingdom of Saudi Arabia (KSA).  A 
search of the PubMed, Google and Google Scholar databases for studies published during the period of 1 January 2002 through 31 
December 2012 was conducted.  We included studies that looked at the number and prevalence of MRSA among total S. aureus. 
Meta-analyst and comprehensive meta-analysis were used for statistical analysis. Twenty six studies were included in the review, 
representing five regions of KSA.  Pooled estimation of 22,793 S. aureus strains showed 35.6% (95% Confidence interval (CI), 0.28 – 
0.42; P < 0.01) of the strains were MRSA with significant heterogeneity.  Prevalence of MRSA ranged from 5.97% to 94% in Dahran 
and Riyadh cities, respectively.  MRSA proportion among KSA regions is slightly high and varied from one city to the other.  
Key words: Saudi – methicillin-resistant Staphylococcucs aureus -systemic review.
  
INTRODUCTION  
S. aureus is a versatile human pathogen that causes 
diseases ranging from mild infection of the skin to life 
threatening sepsis (1). After introduction of penicillin 
in 1940, penicillinase-producing S.aureus were 
detected, leading to development of penicillinase-
resistant semi-synthetic penicillins as methicillin and 
oxacillin. Within a year from this, MRSA were reported 
in United Kingdom (2). The emergence of strains 
resistant to methicillin and other antimicrobial agents 
has become major concern because of the higher 
mortality due to systemic MRSA infections (3).  
Although the rates of isolation of MRSA have been 
increasing throughout the world for the last decades 
and in some areas the rates reached > 50%, there are 
considerable variations in the prevalence of MRSA 
according of geographic area (4,5,6).  
KSA covers over 2 million Km2 area and estimated 
population over 27 million and considered potentially 
hot spot for the collection of MRSA because up to 6 
million of their populations are expatriates from many 
countries. In addition, KSA hosts about four million 
Muslim pilgrims from all over the world (7). KSA 
studies in the early 1990s consistently found low 
MRSA prevalence (5% and 7.5%) which increased 
dramatically up to 91% after 1995 (8). This study aims 
to determine average MRSA prevalence in KSA 
hospitals by conducting a systemic review and meta-
analysis.   
 
MATERIALS AND METHODS 
Data acquisition: literature search was conducted in 
the PubMed and Google Scholar database for the time 
period spanning January 2002 to December 2012. The 
search strategy used keywords (and combinations 
thereof) “Staphylococcus aureus”, “S. aureus”, 
“Prevalence”, “Methecillin”,“ Methecillin-resistant 
Staphylococcus aureus”,  “MRSA” and “Saudi Arabia”. 
Additionally, abstract book of International congress 
on infectious Diseases was explored.  
Inclusion and exclusion criteria: 
The following features were included in the study:  
1- S. aureus samples were collected from 
Saudi hospitals.   
2- . Prevalence of infection or colonization 
with MRSA in patients or residents in 
clinical and nursing healthcare settings 
was reported.  
Studies were excluded for the following reasons: 
1- There were ≤ 2 cases of MRSA bacteremia 
reported.  
2- The study described results that used 
previously published data with  ˃ 1 year 
of overlap or 75% time overlap between 
studies (in these cases, one  
representative study  was chosen).  
3- . Samples were partially/totally selected 
from MRSA culture collections.  4. 
Studies failed to focus on MRSA 
prevalence (these included studies those 
mixed results of “ coagulase-negative 
Staphylococcus and S. aureus or healthy 
people and patients, estimating MRSA 
transmission, or The therapeutic efficacy 
Data extraction  
A data extraction form was developed to collect 
information from MRSA prevalence studies. This 
included study location, study period, specimens 
and/or sites, number of patients or specimens, and 
results present in form of proportions (express as the 
percentage of MRSA cases among isolates of S.aureus.  
Statistical analysis 
Statistical analysis was performed by the use of Meta-
analyst (version 3.13 Beta) and Comprehensive Meta-
Analysis (version 2.0) software. By using Meta-Analyst, 
overall proportion of MRSA in Saudi was pooled by 
forest plot with 95% confidence interval (95% CI). The 
Q statistic for homogeneity and the I2 test were 
calculated to assess whether results varied no more 




(random sampling). A significant heterogeneity was 
considered for P < 0.10 and I2> 50% (9).  The small 
study bias was measured by Begg’s funnel plot and by 
the Egger test (10,11).  
 
RESULTS 
From January 2002 through December 2012, Twenty 
six published articles that matched inclusion criteria 
were selected for meta-analysis (12 - 37). Among these 
publications which reported the prevalence of MRSA 
in KSA, twenty five studies were represented five 
regions only (from thirteen total regions of KSA) and 
one study did not reported location (submitted as 
KSA) (Table 1). Study duration varied between 4 and 
96 months whereas one and five days study period 
were reported in two publications (23,30). Most 
studies, screening was performed as multi-site 
swabbing, most often by additional swabs taken from 
skin lesions, nasal or wounds. While three studies did 
not mentioned screening sites only clinical specimen or 
pediatric and adult population reported (15,16,19).  
As shown in Forest plot (Figure,1) sample size and 95% 
CI of each study was reported. Additionally, pooled 
estimation (Overall) of 22793 S.aureus showed 35.6% 
(95% CI, 0.28 – 0.42; P < 0.01) of strain to be MRSA. 
There was a high level of heterogeneity, random model 
methods (I2= 100%, P <0.001). According to Begg and 
Mazumdar rank correlation test, a significant 
correlation suggests that bias exists but does not 
directly address the implications of this bias (Kindall s 
tau= -0.11) with a 1-tailed P-value = 0.20. 
MRSA proportions variation ranged from 5.97% to 
94.59% in Dahran and Riyadh cities, respectively 
(14,33). Average proportion of MRSA in different KSA 
regions reported that, Al-Gouf recorded <15% in 
contrast to highest prevalence in Assir and Riyadh 
(40%-60%) respectively. Makkah was positioned in 
intermediate value (25%-40%) as MRSA prevalence 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
  
  
   
   
  
  
   
  
   
   
  
   
   
  
   
   
  
   
   
  
   
   
  
   

































































































































   
  
   
   
  
   
   
  
  
   
  





















































































































































In this review, 26 studies on MRSA prevalence in 
different KSA regions were analyzed since 2002 to 
2012.  We summarized the cumulative prevalence of 
MRSA and supplied a map to explain the 
epidemiology of MRSA in Saudi.  
According to our study, the overall estimation of 
MRSA prevalence in Saudi was 35.6% (95% CI, 0.28 – 
0.42). whereas MRSA  prevalence mean was different 
from region to another (Figure, 2). While, variation in 
MRSA proportion exists in several cities (5.97% to 
94%). As we know, meta-analysis studies for MRSA 
prevalence in KSA are not reported but some studies 
mentioned MRSA average. MRSA proportion from 
KSA peer-reviewed studies between 1993 and 1997 is 
low (5-10%) (38). Recently, MRSA prevalence in Saudi 
is closely with our data where detected 29.9% from 
January 1990 through April 2011 (39). This finding 
indicates that temporal increases in MRSA prevalence 
in KSA. One major factor that could drive regional 
MRSA dissemination could be the ineffective of 
infection prevention. Although the reasons for 
variation of MRSA proportion in KSA cities are 
unknown, Van Belkum et al have looked at the clonal 
distribution of MRSA in various part of KSA and 
found that a single clone account 93% of examined 
isolates. Therefore it seems that difference in the 
incidence of MRSA reflects host or environmental 
factors (40). Additionally, high variation may be due 
to epidemiology of MRSA is in transition period and 
infection control rules may be most effective (41). In 
regional perspective, Saudi has a higher prevalence of  
 
 
MRSA than Bahrain, Kuwait, and Lebanon countries. 
In contrast, MRSA prevalence in Egypt, Oman, Iran 
and Jordan was reported more than 50%  (39,42,43) . 
From an international stand, the mean incidence of 
MRSA across China was over 50% and in Shanghi, the 
prevalence was over 80% (44). In Spain, the 
prevalence of MRSA was 29.2% (45). 
Limitations of the study  
1- The studies we review contain data about 
different patient population (up to six 
million of whom are expatriates mainly from 
south and east Asia beside annually a host of 
Muslim pilgrims) 
2- Only five KSA regions which cannot fully 
represent Saudi was pooled data  
3- Due to limited access to in-press articles and 
theses, some studies might been missed 
beside low number of MRSA prevalence 
studies in KSA (26 studies).   
Conclusion 
Our study showed that MRSA proportion among 
KSA studies is slightly high and varied from one city 
to the other. Thus, to combat the MRSA 
dissemination, public health researchers and all 
health professionals must understand the role of 
hospital hygiene protocols and of antimicrobial drug 
policies, as well as mechanisms of regional spread of 
MRSA throughout hospitals. Future systematic 
reviews would also ideally be based on a greater 
number of studies that are of high quality.   
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